Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies-Reference-Cited by-同舟云学术

Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies

Published:2023-08 Issue: Volume:49 Page:109284
ISSN:2352-3409
Container-title:Data in Brief
language:en
Short-container-title:Data in Brief

Author:

Mestrum Stefan G.C.^ORCID,Vanblarcum Roanalis, B.Y.,de Wit Norbert C.J.,Drent Roosmarie J.M.,Boonen Bert T.^ORCID,van Hemert Wouter L.W.^ORCID,Hopman Anton H.N.,Ramaekers Frans C.S.,Leers Math P.G.^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference6 articles.

1. Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes;Raskovalova;PLoS ONE,2022

2. Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: the Cinderella method;Hoffmann;Cytometry A,2022

3. Determination of the proliferative fractions in differentiating hematopoietic cell lineages of normal bone marrow;Nies;Cytometry A,2018

4. Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN;Mestrum;Cytometry B,2021

5. Optimized gating strategy and supporting flow cytometry data for the determination of the Ki-67 proliferation index in the diagnosis of myelodysplastic syndrome;Mestrum;Data Brief,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio;Leukemia Research;2024-07